Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{200803,
        author = {Saba Shafeen and Eeulakanti Srilatha},
        title = {CANCER IMMUNOTHERAPY: AN EMERGING PILLAR IN CANCER TREATMET},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {12},
        number = {12},
        pages = {1691-1694},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=200803},
        abstract = {Our body has natural resistance that can fight with cancer. It was known before the modern medicine, based on the reports where tumors sometimes shrank on their own. One of the successful immunotherapies on cancer was using BCG bacteria for bladder cancer. It was started in 1976 and is still using today. It is done by activating the immune cells to attack cancer cell. Immunotherapy is a strategy, enhances the immune system to eliminate malignant cells. This review article discusses about the types, mechanisms, applications, advantages, and future prospects.},
        keywords = {Cancer Immunotherapeutics; monoclonal antibodies; cancer vaccines; personalized immunotherapy.},
        month = {May},
        }